Physician

Brinda Sri Kantha, D.O.

According to 2025 Medicare claims, Brinda Kantha, D.O. (NPI: 1851452007) practices pain management in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Somerset, NJ. This provider's primary affiliated billing organization is PRACTICE ASSOCIATES MEDICAL GROUP (NPI: 1427016385; TIN: 202088165) and primary practice location at 07059-5847. Kantha is affiliated with the Atlantic ACO (ACO ID: A1026), participating under the MSSP model.

Kantha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 135 traditional Medicare patients, billed 1,010 HCPCS/CPT codes, and received $52,388 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 192 prescription claims across 55 beneficiaries totaling $6,552 in drug costs, led by Celecoxib (Celecoxib). 2017 DME data shows 13 claims. Open Payments data shows 5 records totaling $344. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $15,753 and ending at $6,552. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	89	526	$36,972
2016	84	697	$52,225
2017	91	1,135	$54,462
2018	105	1,546	$62,082
2019	86	1,561	$65,068
2020	82	1,118	$61,428
2021	96	1,097	$62,085
2022	94	1,243	$74,660
2023	93	1,053	$58,741
2024	135	1,010	$52,388

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	34	211	$15,753
2016	34	226	$16,535
2017	37	227	$10,687
2018	40	228	$21,758
2019	50	299	$30,913
2020	40	258	$38,645
2021	38	228	$34,060
2022	37	190	$22,351
2023	29	167	$7,699
2024	55	192	$6,552

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	13	13	$10,259
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	74	74	$141
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	52	86	$112
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	79	135	$76
20553	Injection of trigger points, 3 or more muscles	31	49	$50
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	50	213	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Celecoxib	Celecoxib	25	1,050	$298
Gabapentin	Gabapentin	30	1,468	$279
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	480	$138
Tramadol Hcl	Tramadol Hcl	29	612	$108
Meloxicam	Meloxicam	13	645	$48

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$344	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brinda Sri Kantha, D.O.?

Tedicare shows public-source Medicare data for Brinda Sri Kantha, D.O. (NPI 1851452007), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brinda Sri Kantha, D.O. have ACO affiliation data?

Brinda Sri Kantha, D.O. is shown with ACO affiliation data for Atlantic ACO (MSSP, ACO ID A1026).

What billing organization is linked to Brinda Sri Kantha, D.O.?

Brinda Sri Kantha, D.O. is linked to PRACTICE ASSOCIATES MEDICAL GROUP (billing NPI 1427016385) in the available physician profile data.

Does Brinda Sri Kantha, D.O. have Open Payments data?

Brinda Sri Kantha, D.O. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.